Globus Medical (NYSE:GMED) shares closed up yesterday after the orthopedics company reported preliminary fourth-quarter and 2018 sales numbers that beat the consensus forecast on Wall Street. Audubon, Pa.-based Globus said it expects to post Q4 revenues of $195.5 million and full-year sales of $712.5 million; analysts on The Street were looking for quarterly sales of $188.2 million and […]
Masimo inks $150m credit facility deal
Masimo (NSDQ:MASI) has inked a $150 million credit facility with JP Morgan Chase and Bank of the West, according to a recently published SEC filing. The Irvine, Calif.-based company’s new facility comes with an option to increase the aggregate borrowing capacity up to $550 million, and also provides for a sublimit of up to $25 million […]
FDA chooses 8 medtech companies for opioid crisis challenge
The FDA has selected eight medtech companies to develop devices to help reduce the country’s opioid abuse crisis. More than 250 companies submitted entries to the FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder, announced in May. Those selected include Masimo Corp. and deep-brain-stimulation company Brainsway Ltd. The companies will be expected to […]
Masimo Q3 beats The Street
Masimo (NSDQ:MASI) today released third quarter earnings that topped expectations on Wall Street and lifted its guidance for the remaining year. The Irvine, Calif.-based company posted profits of $57.1 million, or $1.02 per share, on sales of $210.6 million for the three months ended September 29, for bottom-line growth of 59.3% on sales growth of 8.9% […]
Masimo wins FDA nod for improved RD SET sensors
Masimo (NSDQ:MASI) said today it won FDA 510(k) clearance for its RD SET sensors with measure-through motion and low perfusion SET pulse oximetry. The newly cleared sensors feature improved SpO2 accuracy specifications for patients under 3kg, the Irvine, Calif.-based company said, and are designed to improve accuracy, patient comfort and clinician workflows. “We’re delighted to be […]
Where medtech is putting its money this November
Republicans reaped nearly $3.3 million in federal political contributions from the medtech industry in the 2017-18 election cycle, compared with $1.85 million for Democrats, according to data collected by the Center for Responsive Politics, a nonprofit campaign finance watchdog group. Medtech has “historically been a little more Republican than the average industry,” said Andrew Mayersohn, committees researcher […]
FDA clears Masimo’s Rainbow acoustic monitors for infants, neonates
Masimo (NSDQ:MASI) said today it won FDA clearance for its RAS-45 acoustic respiration sensor as part of its Rainbow Acoustic Monitoring system, cleared for use with infants and neonatal patients. With the clearance, the Rainbow Acoustic Monitoring system is now cleared for use with patients of all sizes, the Irvine, Calif.-based company said. Previously, the system […]
Masimo touts study exploring ORi’s ability to detect oxygenation during moderate hyperoxia
Masimo (NSDQ:MASI) today released results from a study exploring the ability of the company’s Oxygen Reserve Index (ORi) to show trends in oxygenation during moderate hyperoxia. The company’s ORi measure is intended to serve as a non-invasive, relative indicator of an individual’s oxygen reserve during moderate hypoxia. The measurement can be trended and can be used […]
Study: Home baby pulse oximetry monitors may be inaccurate, unnecessary
Baby monitors designed to track physiological conditions may be inaccurate and cause parents more stress than necessary, according to a new report published in the Journal of the American Medical Association. Researchers at the Children’s Hospital of Philadelphia studied two such monitors, the Owlet Smart Sock2 and the Baby Vida, both of which are not […]
Masimo, Dominion bury the hatchet in blood monitoring IP infringement suit
Diagnostic tech developer Masimo (NSDQ:MASI) and rival Dominion have settled a suit over blood monitoring patents, according to recently released court documents. The two companies said they reached a settlement deal over a suit brought against Masimo by Dominion claiming it infringed on patents related to noninvasive blood monitoring technology. The agreement does not include payments […]
Masimo touts study exploring pulse oximetry pre-screening for OSA in children with down syndrome
Masimo (NSDQ:MASI) yesterday released results from a study exploring home pulse oximetry monitoring’s ability to serve as an initial screening method to determine which children with Down syndrome should be recommended to undergo sleep studies to diagnose obstructive sleep apnea. The Irvine, Calif.-based company said that children with Down syndrome are at high risk of obstructive […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 21
- Next Page »
